Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life

Authors: Crucitt M.A.; Hyman W.; Grote T.; Tester W.; Madajewicz S.; Yee S.; Wentz A.; Griffin D.; Parasuraman T.V.; Bryson J.

Source: Clinical Therapeutics, Volume 18, Number 4, July 1996 , pp. 778-788(11)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0149-2918(96)80226-8

Affiliations: 1: aSharp Rees-Stealy Medical Group, Inc., , San Diego, California, U.S.A.

Publication date: 1996-07-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Crucitt M.A. ;  Hyman W. ;  Grote T. ;  Tester W. ;  Madajewicz S. ;  Yee S. ;  Wentz A. ;  Griffin D. ;  Parasuraman T.V. ;  Bryson J.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers